Allarity Therapeutics, Inc. Financing Interest Expense
Allarity Therapeutics, Inc. (ALLR) reported Financing Interest Expense of $902.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:FinancingInterestExpense · last filed 2023-11-14
- Allarity Therapeutics, Inc. financing interest expense for the quarter ending 2023-09-30 was $526.00K.
- Allarity Therapeutics, Inc. financing interest expense for the quarter ending 2023-06-30 was $367.00K.
- Allarity Therapeutics, Inc. financing interest expense for the quarter ending 2023-03-31 was $9.00K.
- Allarity Therapeutics, Inc. financing interest expense for the quarter ending 2021-12-31 was -$342.00K.
- Allarity Therapeutics, Inc. financing interest expense for fiscal 2022 was $51.00K, a 0.00% change from fiscal 2021.
- Allarity Therapeutics, Inc. financing interest expense for fiscal 2021 was $51.00K, a 0.00% change from fiscal 2020.
- Allarity Therapeutics, Inc. financing interest expense for fiscal 2020 was $51.00K.
| Period end | Financing Interest Expense 1 month | Financing Interest Expense 3 month | Financing Interest Expense 6 month | Financing Interest Expense 9 month | Financing Interest Expense 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $526.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $893.00K derived: sum of 2 quarters · filed 2023-11-14 | $902.00K 10-Q · filed 2023-11-14 | ||
| 2023-07-31 | $679.00K 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | $367.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $376.00K 10-Q · filed 2023-08-14 | |||
| 2023-04-30 | $156.00K 10-Q · filed 2023-11-14 | ||||
| 2023-03-31 | $9.00K 10-Q · filed 2023-05-11 | ||||
| 2022-12-31 | $51.00K 10-K · filed 2023-03-13 | ||||
| 2021-12-31 | -$342.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $51.00K 10-K · filed 2023-03-13 | |||
| 2021-09-30 | $393.00K 10-Q · filed 2022-11-14 | ||||
| 2020-12-31 | $51.00K 10-K · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |